DRUG
DRUG
NASDAQ · Biotechnology

Bright Minds Biosciences Inc

$71.62
-0.66 (-0.91%)
As of Mar 22, 10:12 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -62.4% upside
Low Target $16.82
Average Target $26.95
High Target $32.06
Current Price $71.62
Current
$71.62
Target
$26.95
$16.82 $26.95 avg $32.06
Scenario Analysis
Bear Case
$16.82
-76.5%
Low target
Base Case
$26.95
-62.4%
Avg target
Bull Case
$32.06
+-55.2%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$170.00
-57.9% from high
52-Week Low
$33.01
+117.0% from low
Target vs 52W High
$26.95
-84.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%